(Q30611207)

English

Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

Induction chemotherapy in metastatic neuroblastoma--does dose influence response? A critical review of published data standards, options and recommendations (SOR) project of the National Federation of French Cancer Centres (FNCLCC). (English)

1 reference

Europe PubMed Central

25 June 2017

0 references

0 references

0 references

National Federation of French Cancer Centres

0 references

author name string

Pinkerton CR

1

1 reference

Europe PubMed Central

25 June 2017

Blanc Vincent MP

2

1 reference

Europe PubMed Central

25 June 2017

Bergeron C

3

1 reference

Europe PubMed Central

25 June 2017

Fervers B

4

1 reference

Europe PubMed Central

25 June 2017

Philip T

5

1 reference

Europe PubMed Central

25 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2000

1 reference

Europe PubMed Central

25 June 2017

European Journal of Cancer

1 reference

Europe PubMed Central

25 June 2017

36

1 reference

Europe PubMed Central

25 June 2017

1808-1815

1 reference

Europe PubMed Central

25 June 2017

14

1 reference

Europe PubMed Central

25 June 2017

Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential cisplatin/VM-26 and vincristine/cyclophosphamide/doxorubicin in metastatic neuroblastoma: an effective alternating non-cross-resistant regimen?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Coordinated use of sequentially escalated cyclophosphamide and cell-cycle-specific chemotherapy (N4SE protocol) for advanced neuroblastoma: experience with 100 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive use of cyclophosphamide in ablation of neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose rapid schedule chemotherapy for disseminated neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide/doxorubicin vs. cisplatin/teniposide in the treatment of children older than 12 months of age with disseminated neuroblastoma: a Pediatric Oncology Group Randomized Phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of advanced neuroblastoma. Results of the spanish neuroblastoma study group (SNSG) studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900189-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(00)00189-1

1 reference

Europe PubMed Central

25 June 2017

1 reference

Europe PubMed Central

25 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30611207&oldid=1606176744"